We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Minimally Invasive Way to Remove Pituitary Tumors

By HospiMedica staff writers
Posted on 13 Feb 2003
Removing pituitary tumors through the nasal cavity rather than beneath the upper lip offers patients a minimally invasive alternative with similar results, less discomfort, and faster recovery, according to a new study published in the February 2003 issue of the Journal of Neurosurgery.

The older, sublabial approach involves an incision beneath the upper lip and extensive dissection in and around the nasal cavity. More...
The procedure can cause long-term patient discomfort, including impaired nasal function and numbness of the upper lip and teeth.

In the new study, 100 consecutive patients who underwent the new endonasal procedure at the University of California, Los Angeles, Medical Center (UCLA, USA) later completed a questionnaire prepared by the researchers. Fourteen of these respondents had undergone prior sublabial procedures. Among the findings from the questionnaire were that remission rates with the new procedure were comparable to those found with the sublabial procedure. Twelve of the 14 patients with prior sublabial surgery preferred the new procedure.

The most common post-surgical complaints were nasal packing, removing of packing, and mouth breathing. Around three months after surgery, 83% of patients had no facial pain, 75% had no nasal congestion, 77% had no decreased nasal airflow, 73% had no decreased sense of smell, and 87% had no upper lip numbness.

"Our study suggests the direct endonasal approach to removing pituitary tumors offers a more direct surgical route, a low complication rate, and minimal postoperative discomfort,” said Dr. Daniel Kelly, associate professor of neurosurgery at the UCLA School of Medicine.




Related Links:
UCLA Medical Ctr

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
External Defibrillator
HeartSave Y | YA
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.